Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

A11 is a cell-penetrating peptide composed of the HIV-1 Tat protein transduction domain linked to an 11-amino acid peptide corresponding to residues 20-30 of the annexin A1 N-terminus.1 It decreases annexin A1 binding to Eph receptor tyrosine kinase A2 (EphA2) and increases EphA2 ubiquitination in HK1 nasopharyngeal carcinoma (NPC) cells. A11 (10 µM) inhibits HK1 and 5-8F NPC cell proliferation, migration, and invasion. In vivo, A11 reduces tumor volume in 5-8F and HK1 NPC mouse xenograft models.
WARNING This product is not for human or veterinary use.
1. ANXA1 binds and stabilizes EphA2 to promote nasopharyngeal carcinoma growth and metastasis. Cancer Res. 80(20), 4386-4398 (2020).